Apr 17, 2026 04:02PM
Apr 17, 2026 04:02PM
Apr 15, 2026 12:41AM
Apr 15, 2026 12:41AM
Apr 13, 2026 04:02PM
Apr 13, 2026 04:01PM
Jan 5, 2026 04:05PM Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan 6, 2025 04:05PM
Dec 6, 2024 07:08AM
Dec 5, 2024 04:05PM
Dec 4, 2024 06:06AM
Dec 3, 2024 10:38PM
Dec 2, 2024 04:31PM
Dec 2, 2024 04:31PM Revolution Medicines Announces Commencement of Public Offering of Common Stock
Oct 15, 2024 07:00PM
Sep 30, 2024 08:30AM
Sep 25, 2024 11:00AM
Jul 16, 2024 05:52AM
Feb 26, 2024 04:05PM
Jan 4, 2024 07:00AM
Sep 18, 2023 06:16AM Revolution Medicines (RVMD) Added to JPMorgan Analyst Focus List
Mar 7, 2023 04:02PM
Mar 3, 2023 05:48AM
Mar 2, 2023 09:15PM
Mar 1, 2023 04:18PM
Mar 1, 2023 04:17PM
Feb 28, 2023 03:56PM
Feb 28, 2023 04:41AM JPMorgan Upgrades Revolution (RVMD) to Overweight
Jan 3, 2023 07:00AM
Jul 22, 2022 04:02PM
Jul 22, 2022 04:02PM
Jul 20, 2022 05:47AM
Jul 19, 2022 10:41PM
Jul 19, 2022 10:41PM
Jul 19, 2022 04:01PM Revolution Medicines (RVMD) Announces Commencement of $200M Public Offering of Common Stock
Jul 19, 2022 04:01PM
Jul 19, 2022 04:01PM
Jan 11, 2022 02:16PM
Jan 11, 2022 02:15PM
Jan 4, 2022 07:30AM
Mar 9, 2021 07:30AM
Mar 9, 2021 07:30AM Revolution Medicines to Participate in Upcoming Investor Conferences
Feb 8, 2021 04:01PM
Feb 4, 2021 05:57AM
Feb 3, 2021 11:30PM
Feb 1, 2021 04:08PM
Feb 1, 2021 04:01PM
Jan 5, 2021 07:30AM
Jul 13, 2020 04:01PM Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jul 9, 2020 05:55AM

287,790 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All